Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health
Chiara Mazziotta, Mauro Tognon, Fernanda Martini, et al.
Cells (2023) Vol. 12, Iss. 1, pp. 184-184
Open Access | Times Cited: 351
Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study
Yiwen Long, Lanhua Tang, Yangying Zhou, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 250
Molecular targeted therapy for anticancer treatment
Hye‐Young Min, Ho‐Young Lee
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 10, pp. 1670-1694
Open Access | Times Cited: 247
Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
Despoina Chrysostomou, Lauren A. Roberts, Julian R. Marchesi, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 198-213
Open Access | Times Cited: 131
Tumor microenvironment signaling and therapeutics in cancer progression
Anshika Goenka, Fatima Khan, Bhupender Verma, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 525-561
Open Access | Times Cited: 117
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Yi Hu, Qinglin Hu, Yongsheng Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 104
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 79
Forty Years of Molecular Diagnostics for Infectious Diseases
Jonathan E. Schmitz, Charles W. Stratton, David H. Persing, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 10
Open Access | Times Cited: 75
Why traditional herbal medicine promotes wound healing: Research from immune response, wound microbiome to controlled delivery
Zeyu Xu, Mei Dong, Shaoping Yin, et al.
Advanced Drug Delivery Reviews (2023) Vol. 195, pp. 114764-114764
Closed Access | Times Cited: 58
Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study
Lawson Eng, Rinku Sutradhar, Yue Niu, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 17, pp. 3122-3134
Closed Access | Times Cited: 49
Fecal microbiota transplantation: current challenges and future landscapes
Abbas Yadegar, Haggai Bar‐Yoseph, Tanya Monaghan, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Open Access | Times Cited: 43
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Ze-Hua Li, Weixi Xiong, Liang Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 31
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
Chun Ye, Xiao Liu, Zilun Liu, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 22
Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy
Yunwei Yang, Yaping An, Yue Dong, et al.
EBioMedicine (2024) Vol. 100, pp. 104967-104967
Open Access | Times Cited: 18
Bifidobacterium modulation of tumor immunotherapy and its mechanism
Bo Pei, Shixuan Peng, Chuying Huang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 17
Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer
Bowen Li, Zixian Wei, Zhiyue Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 220, pp. 125-138
Open Access | Times Cited: 17
Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era
Shuaiqi Wang, Dianwen Ju, Xian Zeng
Biomedicines (2024) Vol. 12, Iss. 1, pp. 194-194
Open Access | Times Cited: 15
From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Novel clinical trial designs emerging from the molecular reclassification of cancer
Mina Nikanjam, Shumei Kato, Teresa Allen, et al.
CA A Cancer Journal for Clinicians (2025)
Open Access | Times Cited: 3
Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context
Yao Liu, Lili Niu, Nannan Li, et al.
Advanced Science (2023) Vol. 10, Iss. 12
Open Access | Times Cited: 31
Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway
Jianwei Zhang, Dan Zhang, Haisen Yin, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Mediterranean diet and olive oil, microbiota, and obesity-related cancers. From mechanisms to prevention
Enrique Almanza‐Aguilera, Ainara Cano, Mercedes Gil‐Lespinard, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 103-119
Open Access | Times Cited: 28
Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure
Jean‐Luc Raoul, Camille Moreau-Bachelard, Marine Gilabert, et al.
ESMO Open (2023) Vol. 8, Iss. 1, pp. 100880-100880
Open Access | Times Cited: 25
A Large Genetic Causal Analysis of the Gut Microbiota and Urological Cancers: A Bidirectional Mendelian Randomization Study
Zhaofa Yin, Bohan Liu, Shijian Feng, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 4086-4086
Open Access | Times Cited: 24
Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy
Rui Fu, Borui Zhao, Min Chen, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top